Sir Salvador Moncada | |
---|---|
Born | |
Other names | Salvador Enrique Moncada Seidner |
Citizenship | United Kingdom Honduras |
Alma mater | |
Known for | Prostacyclin |
Spouses |
|
Children | 4 |
Awards | |
Scientific career | |
Fields | Pharmacology |
Institutions | |
Website | manchester |
Sir Salvador Enrique Moncada Seidner, FRS, FRCP, FMedSci (born 3 December 1944) is a Honduran-British pharmacologist and professor. He is currently Research Domain Director for Cancer at the University of Manchester.[3]
In the past, he was the Research Director of the Wellcome Research Laboratories from 1986 to 1995 and, until recently, the Director of the UCL Wolfson Institute, which he established at University College London in 1996. His research interests include inflammation and vascular biology and he is currently working on the regulation of cell proliferation. He gained fame for his discoveries related to nitric oxide function and metabolism, and his exclusion from the 1996 Lasker Award and the 1998 Nobel Prize in medicine.[4][5][6][7][8][9][10]
Sir Salvador was nominated by Xiomara Castro, the President of Honduras, to serve as their first Ambassador to China following the Honduran government's recognition of the People's Republic of China in March 2023. The Embassy in Beijing was opened in June 2023.[11]
{{cite web}}
: CS1 maint: archived copy as title (link)